Pacira BioSciences (NASDAQ:PCRX) reported its Q1 earnings results on Wednesday, May 3, 2023 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Pacira BioSciences missed estimated earnings by 14.52%, reporting an EPS of $0.53 versus an estimate of $0.62.
Revenue was up $2.35 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 1.9% increase in the share price the next day.
Here’s a look at Pacira BioSciences’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.83 | 0.76 | 0.88 | 0.83 |
| EPS Actual | 0.80 | 0.64 | 0.51 | 0.64 |
| Revenue Estimate | 173.50M | 168.89M | 171.43M | 159.49M |
| Revenue Actual | 171.96M | 167.47M | 169.41M | 157.99M |
To track all earnings releases for Pacira BioSciences visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
